Dyadic Applied BioSolutions (NASDAQ: DYAI) is a global biotechnology company focused on the large-scale production of high-value, strategic input proteins for non-therapeutic applications across the life sciences, food & nutrition, and bio industrial sectors. These proteins serve as essential components in bioprocessing, formulation, and product development, enabling innovation without the regulatory complexity and high costs associated with therapeutic biologics.